A Bibliometric Study: 45 Years of Biomedical Literature in Hematopoietic Stem Cell Transplantation
Abstract
Introduction: Bibliometric measures variables from the scientific literature that are described quantitatively by means of statistical analysis; this tool seeks to demonstrate the impact of hematopoietic stem cell transplants in the literature throughout the last 45 years. Objective: To describe the indexed medical literature in MEDLINE from 1970 to 2015 on hematopoietic stem cell transplants. Methodology: A search of the MEDLINE database through GoPubMed and Fabumed was performed. The search strategy was: Hematopoietic Stem Cell Transplantation [Majr] and 1970:2015 [dp]. The variables analyzed were the number of publications per year, journals, countries and percentage of publications on hematopoietic stem cell transplants. Results: 23,295 references were recovered on hematopoietic stem cell transplants. 1,844 different journals were identified, the largest number of publications was found in Bone Marrow Transplantation with 2,443 publications, followed by Blood with 1,375 and Biology of Bone Marrow Transplantation with 1,319 references. The United States was the country with the highest number of publications with 7,491 (32.15%), in Latin America 324 (1.39%) were published. The most researched descriptors of literature related to the topic were: Transplantation of hematopoietic stem cells with 23,345 publications, humans with 22,019 and stem cells with 17,564. Conclusions: The publications on hematopoietic stem cell transplants have increased progressively during the 45 years studied. The developed countries are the ones that have done more research on the subject, in contrast to the number of publications in total. [Rios-Moreno JV, Bueno-Florez SJ, Conde-Hurtado DI, Tarazona N, Sossa-Melo Claudia Lucía. A Bibliometric Study: 45 Years of Biomedical Literature in Hematopoietic Stem Cell Transplantation. MedUNAB 2017-2018; 20(3): 319-326].
References
2. Moreno ME, Rosselli DA. Análisis bibliométrico de temas económicos en oncología. MedUNAB. 2012; 14(3):160-166. Disponible en: http://132.248.9.34/hevila/Medunab/2011-12/vol14/no3/3.pdf
3. Li D, Wang L, Zhu H, Dou L, Liu D, Fu L, et al. Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies. PLoS One. 2015; 10(7):e0132620. Disponible en: https://doi.org/10.1371/journal.pone.0132620
4. Bladé J, Samson D, Reece D, Apperley J, Björkstrand, Gahrton G, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. British Journal of Haematology. 1998; 102(5):1115-1123. Disponible en: https://doi.org/10.1046/j.1365-2141.1998.00930.x
5. Wang X, Li Y, Yan X. Efficacy and Safety of Novel Agent-Based Therapies for Multiple Myeloma: A Meta-Analysis. BioMed Research International. [Internet]. 2016. [Citado en abril 20 del 2016]. Disponible en: https://www.hindawi.com/journals/bmri/2016/6848902/cta/
6. Li D, Wang L, Zhu H, Dou L, Liu D, Fu L, et al. Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies. PLoS One. 2015; 10(7):e0132620. Disponible en: https://doi.org/10.1371/journal.pone.0132620
7. Chaudhri NA, Aljurf M, Almohareb FI, Alzahrani HA, Bashir Q, Savani B, et al. Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies. Hematol Oncol Stem Cell Ther. 2017; 10(4):173-177. Disponible en: https://doi.org/10.1016/j.hemonc.2017.05.016
8. Jaimovich G, Martinez J, Baldomero H, Rivas M, Hanesman I, Bouzas L, et al. Latin America: the next region for haematopoietic transplant progress. Bone Marrow Transplantation.2017; 52(5):671-677. Disponible en: https://doi.org/ 10.1038/bmt.2016.361
9. Instituto Nacional de Salud. Instituto Nacional de Salud respalda la tradición científica y técnica de trasplantes de médula ósea en Colombia. [Internet]. 2016. [Citado abril 20 2016]. Disponible en: http://www.ins.gov.co/Noticias/Paginas/el-instituto-nacional-de-salud-respalda-la-tradicion-cientifica-y-tecnica-de-trasplantes-de-medula-osea-en-colombia-.aspx#.WEqhcLLhDIV
10. Clínica FOSCAL. Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle. [Internet]. 2015. [citado abril 13 de 2017]. Disponible en: http://www.foscal.com.co.
11. Sossa C, Peña A, Pérez C, Ochoa M, Meléndez H, Salazar L, et al . Clinical utility of the hematopoietic precursor cells (HPC) count compared to the CD+34 cell count in peripheral blood for prediction of apheresis performance:AB15. Nature. 2016; 51:569-569.
12. Centro de Excelencia en Hemofilias. Social networking. [Internet]. 2016. [Citado abril 13 de 2017]. Disponible en: http://ceht.fundacionisa.org/fb
13. MEDLINE. Resources Guide. [Internet]. 2006. [citado junio 28 2016]. Disponible en: https://www.nlm.nih.gov/bsd/pmresources.html
14. Harzing A, Adams D. Publish or Perish: realising Google Scholar’s potential to democratise citation analysis. [Internet]. 2016. [citado junio 28 2016]. Disponible en: https://harzing.com/download/gsday_madrid.pdf
15. University of Maryland. Bibliometrics and Altmetrics: Measuring the impacto f Knowledge. [Internet]. 2017. [Citado junio 28 2016]. Disponible en: http://lib.guides.umd.edu/bibliometrics/SNIP
16. Leiden University. Centre for Science and Technology Studies. [Internet]. 2016. [Citado julio 01 2016]. Disponible en: https://www.cwts.nl
17. Tarazona N. Stem cell transplantation AND 1970:2015 [dp]. [Internet]. 2016. [citado junio 28 2016]. Disponible en: http://ceht.fundacionisa.org/fb
18. Zhang L, Ye X, Sun Y, Deng A, Qian B. Hematology research output from Chinese authors and other countries: a 10-year survey of the literature. Journal of Hematology & Oncology. 2015;8(1):1-3. Disponible en: https://doi.org/10.1186/s13045-014-0103-3
19. Lin C, Ho Y. A Bibliometric Analysis of Publications on Pluripotent Stem Cell Research. Cell J. 2015; 17(1):59-70. Disponible en: https://doi.org/ 10.22074/cellj.2015.512
20. Glynn R, Chin J, Kerin M, Sweeney K. Representation of Cancer in the Medical Literature - A Bibliometric Analysis. PLoS ONe. 2010; 5(11):e13902. Disponible en: https://doi.org/10.1371/journal.pone.0013902
21. Cornelissen J, Versluis J, Passweg J, van Putten W, Manz M, Maertens J, et al. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years. Leukemia. 2014; 29(5):1041-1050. Disponible en: https://doi.org/ 10.1038/leu.2014.332
22. Shah N, Callander N, Ganguly S, Gul Z, Hamadani M, Costa L, et al. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015; 21(7):1155-1166. Disponible en: https://doi.org/10.1016/j.bbmt.2015.03.002
23. Perales M, Ceberio I, Armand P, Burns L, Chen R, Cole P, et al. Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015; 21(6):971-983. Disponible en: https://doi.org/10.1016/j.bbmt.2015.02.022
24. Peffault de Latour R, Peters C, Gibson B, Strahm B, Lankester A, de Heredia C, et al. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes. Bone Marrow Transplant. 2015; 50(9):1168-1172. Disponible en: https://doi.org/10.1038/bmt.2015.117
25. Acevedo A, Gómez A, Becerra H, Ríos A, Zambrano P, Obando E, et al. Distribution and trends of hematology and oncology research in Latin America: A decade of uncertainty. Cancer. 2013; 120(8):1237-1245. Disponible en: https://doi.org/10.1002/cncr.28539
Downloads
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
